98 related articles for article (PubMed ID: 8387028)
1. Interaction of urokinase-type plasminogenactivator (u-PA) with its cellular receptor (u-PAR) induces phosphorylation on tyrosine of a 38 kDa protein.
Dumler I; Petri T; Schleuning WD
FEBS Lett; 1993 May; 322(1):37-40. PubMed ID: 8387028
[TBL] [Abstract][Full Text] [Related]
2. Defective cell migration in an ovarian cancer cell line is associated with impaired urokinase-induced tyrosine phosphorylation.
Mirshahi SS; Lounes KC; Lu H; Pujade-Lauraine E; Mishal Z; Bénard J; Bernadou A; Soria C; Soria J
FEBS Lett; 1997 Jul; 411(2-3):322-6. PubMed ID: 9271229
[TBL] [Abstract][Full Text] [Related]
3. Urokinase-type plasminogen activator induces tyrosine phosphorylation of a 78-kDa protein in H-157 cells.
Bhat GJ; Gunaje JJ; Idell S
Am J Physiol; 1999 Aug; 277(2):L301-9. PubMed ID: 10444524
[TBL] [Abstract][Full Text] [Related]
4. Induction of c-fos gene expression by urokinase-type plasminogen activator in human ovarian cancer cells.
Dumler I; Petri T; Schleuning WD
FEBS Lett; 1994 Apr; 343(2):103-6. PubMed ID: 8168613
[TBL] [Abstract][Full Text] [Related]
5. A 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator. Identification in human tumor cell lines and partial purification.
Nielsen LS; Kellerman GM; Behrendt N; Picone R; Danø K; Blasi F
J Biol Chem; 1988 Feb; 263(5):2358-63. PubMed ID: 2828365
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of the murine cell surface receptor for the urokinase-type plasminogen activator.
Solberg H; Løber D; Eriksen J; Ploug M; Rønne E; Behrendt N; Danø K; Høyer-Hansen G
Eur J Biochem; 1992 Apr; 205(2):451-8. PubMed ID: 1374026
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the binding of urokinase-type plasminogen activator (u-PA) to plasminogen, to plasminogen-activator inhibitor-1 and to the u-PA receptor.
Lijnen HR; De Cock F; Collen D
Eur J Biochem; 1994 Sep; 224(2):567-74. PubMed ID: 7925373
[TBL] [Abstract][Full Text] [Related]
8. Proteolytically active streptococcal pyrogenic exotoxin B cleaves monocytic cell urokinase receptor and releases an active fragment of the receptor from the cell surface.
Wolf BB; Gibson CA; Kapur V; Hussaini IM; Musser JM; Gonias SL
J Biol Chem; 1994 Dec; 269(48):30682-7. PubMed ID: 7982988
[TBL] [Abstract][Full Text] [Related]
9. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
Margheri F; D'Alessio S; Serratì S; Pucci M; Del Rosso A; Benelli R; Ferrari N; Noonan DM; Albini A; Fibbi G; Del Rosso M
Int J Oncol; 2005 Jul; 27(1):223-35. PubMed ID: 15942664
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and alpha(2)-macroglobulin receptor in human breast carcinomas.
Christensen L; Wiborg Simonsen AC; Heegaard CW; Moestrup SK; Andersen JA; Andreasen PA
Int J Cancer; 1996 May; 66(4):441-52. PubMed ID: 8635858
[TBL] [Abstract][Full Text] [Related]
11. Expression of urokinase-type plasminogen activator (u-PA), u-PA receptor, and tissue-type PA messenger RNAs in human hepatocellular carcinoma.
De Petro G; Tavian D; Copeta A; Portolani N; Giulini SM; Barlati S
Cancer Res; 1998 May; 58(10):2234-9. PubMed ID: 9605771
[TBL] [Abstract][Full Text] [Related]
12. Increase of a urokinase receptor-related low-molecular-weight molecule in colorectal adenocarcinomas.
Lau HK; Kim M; Koo J; Chiu B; Murray D
Clin Exp Metastasis; 1995 Nov; 13(6):492-8. PubMed ID: 7586807
[TBL] [Abstract][Full Text] [Related]
13. Urokinase binding and receptor identification in cultured endothelial cells.
Haddock RC; Spell ML; Baker CD; Grammer JR; Parks JM; Speidel M; Booyse FM
J Biol Chem; 1991 Nov; 266(32):21466-73. PubMed ID: 1657968
[TBL] [Abstract][Full Text] [Related]
14. Interaction of urokinase-type plasminogen activator with its receptor rapidly induces activation of glucose transporters.
Anichini E; Zamperini A; Chevanne M; Caldini R; Pucci M; Fibbi G; Del Rosso M
Biochemistry; 1997 Mar; 36(11):3076-83. PubMed ID: 9115983
[TBL] [Abstract][Full Text] [Related]
15. Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor.
Fibbi G; Caldini R; Chevanne M; Pucci M; Schiavone N; Morbidelli L; Parenti A; Granger HJ; Del Rosso M; Ziche M
Lab Invest; 1998 Sep; 78(9):1109-19. PubMed ID: 9759655
[TBL] [Abstract][Full Text] [Related]
16. Binding of human single chain urokinase to Chinese Hamster Ovary cells and cloning of hamster u-PAR.
Fowler B; Mackman N; Parmer RJ; Miles LA
Thromb Haemost; 1998 Jul; 80(1):148-54. PubMed ID: 9684801
[TBL] [Abstract][Full Text] [Related]
17. Cellular receptor for urokinase-type plasminogen activator: protein structure.
Behrendt N; Ploug M; Rønne E; Høyer-Hansen G; Danø K
Methods Enzymol; 1993; 223():207-22. PubMed ID: 8271954
[No Abstract] [Full Text] [Related]
18. The urokinase receptor and cell migration.
Blasi F
Semin Thromb Hemost; 1996; 22(6):513-6. PubMed ID: 9122717
[TBL] [Abstract][Full Text] [Related]
19. Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol.
Ploug M; Rønne E; Behrendt N; Jensen AL; Blasi F; Danø K
J Biol Chem; 1991 Jan; 266(3):1926-33. PubMed ID: 1846368
[TBL] [Abstract][Full Text] [Related]
20. The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants.
Behrendt N; Rønne E; Ploug M; Petri T; Løber D; Nielsen LS; Schleuning WD; Blasi F; Appella E; Danø K
J Biol Chem; 1990 Apr; 265(11):6453-60. PubMed ID: 2156852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
